Arrowhead Pharmaceuticals Inc. buy Piper Sandler
Start price
17.12.25
/
50%
€55.98
Target price
17.12.26
€85.13
Performance (%)
5.82%
Price
23.12.25
€59.24
Summary
This prediction is currently active. With a performance of 5.82%, the BUY prediction by Piper_Sandler for Arrowhead Pharmaceuticals Inc. is trending in the right direction. This prediction currently runs until 17.12.26. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Arrowhead Pharmaceuticals Inc. | 7.358% |
| iShares Core DAX® | 1.732% |
| iShares Nasdaq 100 | 3.304% |
| iShares Nikkei 225® | 2.342% |
| iShares S&P 500 | 2.357% |
Comments by Piper_Sandler for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its price target raised by analysts at Piper Sandler from $70.00 to $100.00. They now have an "overweight" rating on the stock.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by Piper_Sandler for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€34.14
19.11.25
19.11.25
€60.47
19.11.26
19.11.26
73.52%
23.12.25
23.12.25
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.00
27.11.24
27.11.24
€42.54
27.11.25
27.11.25
100.00%
28.11.25
28.11.25
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€16.42
08.10.24
08.10.24
€56.53
08.10.25
08.10.25
91.78%
09.10.25
09.10.25